Nishadil
Signup Signin
Delhi | 25°C (windy)
Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment

Rezdiffra's Global Ascendancy: Madrigal Pharmaceuticals Reshaping NASH Treatment
Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development

Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development
Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave
The NAD+ Revolution: Why ChromaDex's Niagen is a Scientific Marvel Facing Financial Headwinds

The NAD+ Revolution: Why ChromaDex's Niagen is a Scientific Marvel Facing Financial Headwinds
Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining

Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining
Load more..